LY4302814 Clinical Trials (2026): 1 Studies for Healthy
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 LY4302814 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Healthy) and 150 total planned enrollment. 1 LY4302814 clinical trial is actively recruiting at 1 U.S. site across 1 state. Most recent activity: NCT07566338 (Aug 2027).
Where to Participate: All LY4302814 Trial Sites in the U.S. (1 site across 1 state)
Every actively recruiting LY4302814trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| FL | Fortrea Clinical Research Unit | Daytona Beach32117 | NCT07566338 | Map |
LY4302814 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting LY4302814 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07566338 | A Study of LY4302814 in Healthy Participants | P1 | Healthy | 150 | May 2026 |
All LY4302814 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07566338 | A Study of LY4302814 in Healthy Participants | P1 | recruiting | 150 | Eli Lilly and Company | May 2026 |
LY4302814 clinical trials: frequently asked questions
- How many LY4302814 clinical trials are there?
- 1 LY4302814 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are LY4302814 clinical trials recruiting in 2026?
- Yes — 1 LY4302814 trial is actively recruiting in 2026, with 1 U.S. site across 1 state. See the recruiting trials and the per-state site list further down this page.
- What conditions is LY4302814 being studied for?
- LY4302814 is being studied for Healthy. The trials are grouped by indication on this page.
- What phase is LY4302814 in?
- LY4302814 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors LY4302814 clinical trials?
- The lead sponsor across the most LY4302814 trials is Eli Lilly and Company. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming LY4302814as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: